186 related articles for article (PubMed ID: 34619856)
1. Relevance of Additional Immunohistochemical Markers in the Differential Diagnosis of Small B-Cell Lymphomas: A Case-Control Study.
Kıvrak H; Yüksel S; Ateş C; Merter M; Kaygusuz G; Özcan M; Kuzu I
Turk J Haematol; 2022 Aug; 39(3):178-187. PubMed ID: 34619856
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
Patel N; Durkin L; Bodo J; Hsi ED
Am J Clin Pathol; 2020 Apr; 153(5):646-655. PubMed ID: 31953940
[TBL] [Abstract][Full Text] [Related]
3. Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.
Metcalf RA; Monabati A; Vyas M; Roncador G; Gualco G; Bacchi CE; Younes SF; Natkunam Y; Freud AG
Hum Pathol; 2014 Aug; 45(8):1730-6. PubMed ID: 24925224
[TBL] [Abstract][Full Text] [Related]
4. MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases.
Zhang LF; Zhang Y; Shui RH; Lu HF; Jiang WH; Cai X; Li XQ; Yu BH
Diagn Pathol; 2024 Apr; 19(1):60. PubMed ID: 38627702
[TBL] [Abstract][Full Text] [Related]
5. Study of the Utility of Myeloid Cell Nuclear Differentiation Antigen (MNDA) in the Diagnosis of Marginal Zone Lymphoma.
Gupta N; Roychoudry S; Sticco KL; Hsu P; Zhang X; Sheikh-Fayyaz S
Appl Immunohistochem Mol Morphol; 2023 Apr; 31(4):217-223. PubMed ID: 36867739
[TBL] [Abstract][Full Text] [Related]
6. IRTA1 and MNDA Expression in Marginal Zone Lymphoma: Utility in Differential Diagnosis and Implications for Classification.
Wang Z; Cook JR
Am J Clin Pathol; 2019 Feb; 151(3):337-343. PubMed ID: 30346478
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry for LEF1 and SOX11 adds diagnostic specificity in small B-cell lymphomas.
Rangan A; Reinig E; McPhail ED; Rech KL
Hum Pathol; 2022 Mar; 121():29-35. PubMed ID: 35066013
[TBL] [Abstract][Full Text] [Related]
8. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas.
Tandon B; Peterson L; Gao J; Nelson B; Ma S; Rosen S; Chen YH
Mod Pathol; 2011 Nov; 24(11):1433-43. PubMed ID: 21685909
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of the novel marginal zone B-cell marker IRTA1 in malignant lymphoma.
Ikeda JI; Kohara M; Tsuruta Y; Nojima S; Tahara S; Ohshima K; Kurashige M; Wada N; Morii E
Hum Pathol; 2017 Jan; 59():70-79. PubMed ID: 27666766
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas.
Verdanet E; Dereure O; René C; Tempier A; Benammar-Hafidi A; Gallo M; Frouin E; Durand L; Gazagne I; Costes-Martineau V; Cacheux V; Szablewski V
Histopathology; 2017 Oct; 71(4):648-660. PubMed ID: 28594133
[TBL] [Abstract][Full Text] [Related]
11. MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.
Hamadeh F; MacNamara SP; Aguilera NS; Swerdlow SH; Cook JR
Mod Pathol; 2015 Apr; 28(4):564-74. PubMed ID: 25216226
[TBL] [Abstract][Full Text] [Related]
12. Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation.
Righi S; Novero D; Godio L; Bertuzzi C; Bacci F; Agostinelli C; Sagramoso C; Rossi M; Piccioli M; Gazzola A; Mannu C; Roncador G; Sabattini E
Hum Pathol; 2022 Jun; 124():67-75. PubMed ID: 35339566
[TBL] [Abstract][Full Text] [Related]
13. Identification of MNDA as a new marker for nodal marginal zone lymphoma.
Kanellis G; Roncador G; Arribas A; Mollejo M; Montes-Moreno S; Maestre L; Campos-Martin Y; Ríos Gonzalez JL; Martinez-Torrecuadrada JL; Sanchez-Verde L; Pajares R; Cigudosa JC; Martin MC; Piris MA
Leukemia; 2009 Oct; 23(10):1847-57. PubMed ID: 19474799
[TBL] [Abstract][Full Text] [Related]
14. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Positivity in Primary Follicles: Potential Pitfall in the Differential Diagnosis With Marginal Zone Lymphoma.
Manohar V; Peerani R; Tan B; Gratzinger D; Natkunam Y
Appl Immunohistochem Mol Morphol; 2020; 28(5):384-388. PubMed ID: 30640752
[TBL] [Abstract][Full Text] [Related]
15. [A study of LEF1 protein expression in diagnosis and differential diagnosis of lymphoblastic lymphoma/acute lymphoblastic leukemia].
Chen X; Rui WW; Bi K; Wu YJ; Zhang SX; Zhang L; Yu J; Xiu B; Yi XH; Zeng Y
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):207-212. PubMed ID: 33677883
[No Abstract] [Full Text] [Related]
16. Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia.
Quintanilla-Martinez L; Sander B; Chan JK; Xerri L; Ott G; Campo E; Swerdlow SH
Virchows Arch; 2016 Feb; 468(2):141-57. PubMed ID: 26416032
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma and other indolent lymphomas, including mantle cell lymphoma.
Yoshino T; Tanaka T; Sato Y
J Clin Exp Hematop; 2020 Dec; 60(4):124-129. PubMed ID: 32249238
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of lymphoid enhancer-binding factor 1 in diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma.
Amador-Ortiz C; Goolsby CL; Peterson LC; Wolniak KL; McLaughlin JL; Gao J; Chen YH
Am J Clin Pathol; 2015 Feb; 143(2):214-22. PubMed ID: 25596247
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Utility of Lymphoid Enhancer Binding Factor 1 Immunohistochemistry in Small B-Cell Lymphomas.
Menter T; Trivedi P; Ahmad R; Flora R; Dirnhofer S; Tzankov A; Naresh KN
Am J Clin Pathol; 2017 Mar; 147(3):292-300. PubMed ID: 28395058
[TBL] [Abstract][Full Text] [Related]
20. Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications.
van den Brand M; Rijntjes J; Hebeda KM; Menting L; Bregitha CV; Stevens WB; van der Velden WJ; Tops BB; van Krieken JH; Groenen PJ
Histopathology; 2017 Jan; 70(2):174-184. PubMed ID: 27297871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]